CRL
$163.36
Revenue | $1032.14Mn |
Net Profits | $52.33Mn |
Net Profit Margins | 5.07% |
Charles River Laboratories International’s revenue jumped 0.59% since last year same period to $1032.14Mn in the Q2 2025. On a quarterly growth basis, Charles River Laboratories International has generated 4.87% jump in its revenue since last 3-months.
Charles River Laboratories International’s net profit fell -41.85% since last year same period to $52.33Mn in the Q2 2025. On a quarterly growth basis, Charles River Laboratories International has generated 105.45% jump in its net profits since last 3-months.
Charles River Laboratories International’s net profit margin fell -42.19% since last year same period to 5.07% in the Q2 2025. On a quarterly growth basis, Charles River Laboratories International has generated 95.9% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 2.38 |
EPS Estimate Current Year | 2.38 |
Charles River Laboratories International’s earning per share (EPS) estimates for the current quarter stand at 2.38 - a -4.8% fall from last quarter’s estimates.
Charles River Laboratories International’s earning per share (EPS) estimates for the current year stand at 2.38.
Earning Per Share (EPS) | 0 |
Charles River Laboratories International’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Charles River Laboratories International has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-08-06 | 2.5 | 3.12 | 24.8% |
2025-10-29 | 2.38 | 0 | -100% |
2025-05-07 | 2.07 | 2.34 | 12.78% |